{"disease":{"id":"urinary-tract-cancer","name":"urinary tract cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06472765","title":"Vaginal Ecosystem and Network in the United States Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3250,"lead_sponsor_name":"Vaginal Biome Science","has_results":false},{"nct_id":"NCT03410641","title":"Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study","phase":"","overall_status":"COMPLETED","enrollment_count":1216,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT02928406","title":"A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1004,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT04031469","title":"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease","phase":"","overall_status":"SUSPENDED","enrollment_count":1000,"lead_sponsor_name":"ProgenaBiome","has_results":false},{"nct_id":"NCT02379429","title":"Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04718948","title":"Multimodal Spectroscopy to Detect Urothelial Cancer in Urine","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"University of Florence","has_results":false},{"nct_id":"NCT05810623","title":"Single-Dose Intravesical Chemotherapy After Diagnostic URS","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":394,"lead_sponsor_name":"David D'Andrea","has_results":false},{"nct_id":"NCT07510685","title":"Closed-System Bladder Irrigation to Reduce Urinary Tract Infections After Endoscopic Urologic Surgery (IRIS Trial)","phase":"NA","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"University of Pisa","has_results":false},{"nct_id":"NCT04498767","title":"Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"European Organisation for Research and Treatment of Cancer - EORTC","has_results":false},{"nct_id":"NCT03333616","title":"Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT05739071","title":"JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","has_results":false},{"nct_id":"NCT03701659","title":"TUPKRP Combined With MAB Therapy for LUTS/PCa","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"The Third Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT04209192","title":"Antimicrobial Prophylaxis in Patients Who Underwent a Transurethral Resection of Bladder (TURB)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","has_results":false},{"nct_id":"NCT03138967","title":"Investigation of Sugammadex in Outpatient Urological Procedures","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT03541902","title":"Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":32,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06822010","title":"SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":28,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":false},{"nct_id":"NCT04430842","title":"Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Quadriga Biosciences, Inc.","has_results":false},{"nct_id":"NCT04583553","title":"Comparative Microbial Analysis of Cystitis in Non-muscle-invasive Bladder Cancer Patients Using Vikor Scientific Urine-ID Testing Menu (IDTM) and Standard Laboratory Culture","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Kansas Medical Center","has_results":false}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}